Depression Clinical Trials in New York, NY

109 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
E-Mindfulness Approaches for Living After Breast Cancer	Phase 3	NRG Oncology	<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression	N/A	LivaNova	<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)	Phase 2	atai Therapeutics, Inc.	<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)	Phase 3	Xenon Pharmaceuticals Inc.	<1 mi
Study to Assess the Safety and Effectiveness of NMRA-335140-501	Phase 3	Neumora Therapeutics, Inc.	<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	Phase 3	Cybin IRL Limited	<1 mi
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer	N/A	Memorial Sloan Kettering Cancer Center	<1 mi
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma	N/A	Memorial Sloan Kettering Cancer Center	<1 mi
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast Cancer	N/A	Memorial Sloan Kettering Cancer Center	<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	N/A	Abbott Medical Devices	<1 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder	Phase 3	Vanda Pharmaceuticals	<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)	Phase 2	Autobahn Therapeutics, Inc.	<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms	Phase 4	Axsome Therapeutics, Inc.	<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)	Phase 2	Seaport Therapeutics	<1 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	<1 mi
Lay-Delivered Behavioral Activation in Senior Centers	N/A	University of Washington	<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms	Phase 3	Janssen Research & Development, LLC	<1 mi
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	<1 mi
SAINT in Postpartum Depression (PPD)	N/A	Magnus Medical	<1 mi
Improving the Mental Health of Home Health Aides	N/A	Weill Medical College of Cornell University	<1 mi
ROSE in Sunset Park	N/A	NYU Langone Health	<1 mi
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33	N/A	NYU Langone Health	<1 mi
Engage & Connect: A Psychotherapy for Postpartum Depression	N/A	Weill Medical College of Cornell University	<1 mi
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression	Phase 2	Icahn School of Medicine at Mount Sinai	<1 mi
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder	Phase 2	Icahn School of Medicine at Mount Sinai	<1 mi
Biomarker-guided rTMS for Treatment Resistant Depression	Phase 3	Weill Medical College of Cornell University	<1 mi
WeCare: A System of Care for Black Youth	N/A	New York University	<1 mi
A Study of Brenipatide in Adult Participants With Major Depressive Disorder	Phase 3	Eli Lilly and Company	<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder	Phase 2	AbbVie	<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder	Phase 3	Intra-Cellular Therapies, Inc.	<1 mi
Maintenance rTMS for Depression (Maitr-De)	N/A	University of California, San Diego	<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder	Phase 2	AbbVie	<1 mi
Accelerated TMS for MDD	N/A	Neuronetics	<1 mi
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)	—	Janssen Research & Development, LLC	<1 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.	Phase 2	LB Pharmaceuticals Inc.	<1 mi
DBS for TRD With the Medtronic Percept PC	N/A	Helen Mayberg, MD	<1 mi
A Digital Intervention for Post-Stroke Depression and Executive Dysfunction	Phase 2	Weill Medical College of Cornell University	<1 mi
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality	N/A	Weill Medical College of Cornell University	<1 mi
Tele-PROTECT Therapy: Effectiveness, Empowerment, and Implementation	N/A	Weill Medical College of Cornell University	<1 mi
Telephone-Based Support Programs for People With Epilepsy	N/A	NYU Langone Health	<1 mi
Neutralizing Interleukin (IL)-6	Phase 2	Icahn School of Medicine at Mount Sinai	<1 mi
Safe Mothers, Safe Children Initiative	N/A	New York University	<1 mi
Accelerated TMS for Depression and OCD	N/A	Weill Medical College of Cornell University	<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression	Phase 2	Draig Therapeutics Ltd	<1 mi
Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
Mindfulness-Based fMRI Neurofeedback for Depression	N/A	Columbia University	<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)	Phase 3	Definium Therapeutics US, Inc.	<1 mi
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)	N/A	NYU Langone Health	<1 mi
Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)	Phase 2	NYU Langone Health	<1 mi
Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)	N/A	NYU Langone Health	<1 mi
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV	Phase 2	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide	N/A	Ksana Health	<1 mi
Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depression	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder	Phase 3	Cybin IRL Limited	<1 mi
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt	N/A	Weill Medical College of Cornell University	<1 mi
Aβ Dynamics in LLMD	Phase 4	NYU Langone Health	<1 mi
A Patient Activation Approach to Implementing Depression Treatment in Cardiac Patients	N/A	Columbia University	<1 mi
Personalized Mobile Cognitive Behavioral Therapy Application	N/A	Weill Medical College of Cornell University	<1 mi
Harlem Strong Mental Health Coalition	N/A	City University of New York, School of Public Health	<1 mi
Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals	N/A	Weill Medical College of Cornell University	<1 mi
Pramipexole to Enhance Social Connections	Phase 2	University of California, San Diego	<1 mi
Prevention of Psychological Health Problems Via Integrated Operational Support	N/A	New York University	<1 mi
Psilocybin-Assisted Therapy for Intergenerational Trauma	Phase 2	Rachel Yehuda	<1 mi
Triage Survey for Psychiatry Research Eligibility	—	Adams Clinical	<1 mi
Mobile Cognitive Behavioral Therapy for Stroke	N/A	Weill Medical College of Cornell University	<1 mi
Assessment of Music Experiences in Navigating Depression Part 2	N/A	Icahn School of Medicine at Mount Sinai	<1 mi
Readiness and Progress in Emotion Regulation Therapy	N/A	Teachers College, Columbia University	<1 mi
An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression	—	Singula Institute	<1 mi
Mobile CBT for Middle Aged and Older Adults	N/A	Weill Medical College of Cornell University	<1 mi
Neural Circuit Effects of Ketamine in Depression	Phase 4	Icahn School of Medicine at Mount Sinai	<1 mi
Virtual Reality for Pain Management in Burn Patients	N/A	Weill Medical College of Cornell University	<1 mi
Brief Interventions for Coping with Distress	N/A	Teachers College, Columbia University	<1 mi
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)	Phase 2	NYU Langone Health	<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	<1 mi
SilverCloud as a School-Based Intervention for Vulnerable Youth	N/A	NYU Langone Health	5 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder	Phase 3	Xenon Pharmaceuticals Inc.	5 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)	Phase 3	Xenon Pharmaceuticals Inc.	5 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response	Phase 2	ACADIA Pharmaceuticals Inc.	5 mi
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder	Phase 2	Janssen Research & Development, LLC	5 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol	Phase 3	Axsome Therapeutics, Inc.	5 mi
Testing Adapted Self-Help Plus (SH+) for Stress and Well-Being in International Students at a U.S. University	N/A	The New School	5 mi
Nebulized Ketamine for the Treatment of Major Depressive Disorder	Phase 3	Theresa Jacob, PhD, MPH	5 mi
DBS for Depression	Phase 1	Northwell Health	9 mi
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults	N/A	New York University	12 mi
Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical Trial	Phase 2	Marianne Goodman	12 mi
Psilocybin to Treat Depression in Spinal Cord Injury	Phase 1/2	James J. Peters Veterans Affairs Medical Center	12 mi
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	12 mi
Suicide Specific Rumination in Veterans	N/A	VA Office of Research and Development	12 mi
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression	N/A	Albert Einstein College of Medicine	12 mi
Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)	N/A	Montefiore Medical Center	12 mi
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus	N/A	Michigan State University	12 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.	Phase 3	AbbVie	12 mi
OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum Depression	N/A	Hackensack Meridian Health	12 mi
Study of ALTO-300 in MDD	Phase 2	Alto Neuroscience	13 mi
ALTO-207 in Adults With Treatment-resistant Depression (TRD)	Phase 2	Alto Neuroscience	16 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	Phase 2	Syndeio Biosciences, Inc	16 mi
Transcranial Direct Current Stimulation for Depression	N/A	Soterix Medical	18 mi
Neural and Psychiatric Consequences of Cannabis Use in Adolescents	N/A	University of Miami	23 mi
A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage AD	N/A	Weill Medical College of Cornell University	26 mi
Mind-Body Skills Group for Graduate Students	N/A	Weill Medical College of Cornell University	26 mi
ENA-001 for Opioid Induced Respiratory Depression	Phase 1	Enalare Therapeutics Inc.	29 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)	Phase 3	Neurocrine Biosciences	37 mi
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy	—	Cefaly Technology	38 mi
Foundational Programs to Combat Clinician Stress	N/A	Lancaster General Hospital	41 mi
PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.	Phase 4	Stony Brook University	48 mi
The Role of mGluR5 in CBT-I	Phase 4	Stony Brook University	48 mi
Combination of Novel Therapies for CKD Comorbid Depression	Phase 2	Stony Brook University	48 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.